The Role of Neuromuscular Blockade Depth in Reducing Fentanyl Consumption by Evaluating Dynamic Postoperative Pain via Pressure Algometry: A Randomized Clinical Trial.
Student's Journal of Health Research Africa · 2026-09-30 · 7 (3) · 9
DOI: 10.51168/nsseh037 ↗Abstract
Background and objectives: Deep neuromuscular blockade (NMB) improves the laparoscopic surgical workspace, but its effect on acute postoperative pain is less well characterized. This study aimed to determine whether deep NMB reduces the minimum effective analgesic dose (MEAD) of fentanyl and X undergoing laparoscopic cholecystectomy. Methods: In this prospective, randomized, double-blind clinical trial, 70 patients undergoing laparoscopic cholecystectomy at a pneumoperitoneum pressure of 10 mmHg were randomized to deep NMB (Group D; post-tetanic count 1–2) or moderate NMB (Group M; train-of-four count 1–2) with cisatracurium. In the post-anaesthesia care unit (PACU), fentanyl 10 µg was titrated every 10 minutes to the MEAD, and pain was scored on a visual analogue scale (VAS) at rest and during 20 N wound compression with a digital algometer. Secondary outcomes were VAS at 2, 6 and 12 hours, surgeon satisfaction and postoperative nausea and vomiting (PONV). Results: Fentanyl MEAD was lower in Group D than in Group M (34.3 ± 6.5 vs 49.4 ± 11.9 µg; median 30 vs 50 µg; P
EUVIMED